Transparency Initiative to provide more information on FDA regulation and drug development

被引：0

|

作者：

Wechsler, Jill

机构：

来源：

FORMULARY | 2010年 / 45卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：232 / 233

页数：2

相关论文

共 50 条

[1] FDA information systems, Sentinel Initiative seek more timely drug safety information
Wechsler, Jill
FORMULARY, 2010, 45 (04) : 136 - 137
[2] FDA's drug safety initiative; Resolutions or more questions?
Young, D
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (13) : 1333 - +
[3] FDA Initiative to Address Gaps in Analgesic Drug Development
Boughton, Barbara
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2011, 4 (01): : 3 - 3
[4] Drug development and the FDA's critical path initiative
Woosley, R. L.
Cossman, J.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (01) : 129 - 133
[5] Newborns and drug studies: The NICHD/FDA newborn drug development initiative
Giacoia, GP
Mattison, DR
CLINICAL THERAPEUTICS, 2005, 27 (06) : 796 - 813
[6] Relationships with the drug industry: More regulation, greater transparency
Krumholz, Harlan M.
Ross, Joseph S.
BRITISH MEDICAL JOURNAL, 2009, 338
[7] FDA Seeks More Timely Drug Information Electronically
Wechsler, Jill
BIOPHARM INTERNATIONAL, 2010, 23 (03) : 18 - 19
[8] The FDA's Patient-Focused Drug Development Initiative
Kluetz, Paul G.
Bhatnagar, Vishal
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (02) : 70 - 72
[9] Drug information reaching more patients, FDA data show
不详
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (02) : 107 - +
[10] PROPOSAL TO PROVIDE MORE PEDIATRIC USE INFORMATION IN DRUG LABELING
NIGHTINGALE, SL
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (18): : 2491 - 2491

← 1 2 3 4 5 →